ICCM is trading 26% down today at $6.91, primarily due to investors locking in profits after a massive multi-day rally. This occurs despite IceCure Medical announcing today that it has officially regained compliance with Nasdaq's minimum bid price requirement. The stock had previously surged over 230% following updates on its U.S. ProSense install base and a $5.5 million private placement.